help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 19, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2533
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/5/1909    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalliokoski, T.
Right arrow Articles by Simell, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalliokoski, T.
Right arrow Articles by Simell, O.
Related Collections
Right arrow Diabetes and Insulin

Submitted on November 17, 2006
Accepted on February 11, 2008

Pancreatic Glucose Uptake in Vivo in Men with Newly Diagnosed Type 1 Diabetes

Teemu Kalliokoski*, Pirjo Nuutila, Kirsi A. Virtanen, Patricia Iozzo, Marco Bucci, Erkki Svedström, Anne Roivainen, Kjell Någren, Tapio Viljanen, Heikki Minn, Juhani Knuuti, Tapani Rönnemaa, and Olli Simell

Department of Pediatrics, University of Turku, Turku, Finland; Turku PET Centre, University of Turku, Turku, Finland; Department of Medicine, University of Turku, Turku, Finland; Department of Radiology, University of Turku, Turku, Finland; Department of Pediatrics, Central Hospital of Seinäjoki, Seinäjoki, Finland

* To whom correspondence should be addressed. E-mail: teemu.kalliokoski{at}utu.fi.

Context. Due to the restricted accessibility of pancreatic tissue in living man, direct analysis of the events preceding development of autoimmune changes in the pancreas has been problematic. In vivo imaging of insulitis might markedly increase understanding of the events and timing of the events that are necessary for the progression toward overt type 1 diabetes.

Design. To evaluate possibilities to visualize insulitis in man in vivo with positron emission tomography (PET), we studied 12 male patients (age 26 ± 7 years) with newly diagnosed type 1 diabetes (duration range 0–7 months) and 9 age and sex-matched healthy controls after an overnight fast using 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) and [11C]methionine. For definition of the regions of interest (ROIs) pancreas was localized with MRI or CT-PET.

Results. Glucose uptake to the pancreas was markedly higher in the patients with type 1 diabetes than in the healthy controls (22.9 ± 6.4 vs. 17.8 ± 6.0 µmol/kg·min, p = 0.039). Glucose uptake to the pancreas of the patients was inversely associated with the duration of diabetes (R = -0.58, p = 0.024), so that in patients with newly diagnosed type 1 diabetes glucose uptake was higher than in the healthy controls or patients with long duration of diabetes. Methionine uptake to the pancreas of the patients was similar as in the controls (3.7 ± 1.9 vs. 4.6 ± 2.4 µmol/kg·min, P = 0.21).

Conclusions. In patients with type 1 diabetes glucose uptake to the pancreas is enhanced at or soon after the time of diagnosis.


Key words: Type 1 diabetes • Imaging • [18F]FDG • [11C]methionine • PET • CT-PET • Insulitis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society